化合物简介
Ranirestat (also known as AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally.
基本信息
中文名称
雷尼司他
英文名称
Ranirestat
中文别名
英文别名
(3R)-2\'-(4-bromo-2-fluorobenzyl)spiro[pyrrolidin-3,4\'(1\'H)-pyrrolo[1,2-a]pyrazin]-1\',2,3\',5(2\'H)-tetraone、Ranirestat、Ranirestat (JAN/INN)、(R)-2-(4-bromo-2-fluorobenzyl)spiro[1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4,3\'-pyrrolidine]-1,2\',3,5\'-tetrone、R-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydro[1,2-a]pyrrolopyridine-4-spiro-3\'-pyrrolidine-1,2\',3\'5\'-tetraone、SX-3202、AS-3201、(3R)-2\'-(4-bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4\'(1\'H)-pyrrolo[1,2-a]pyrazine]-1\',2,3\',5(2H\')-tetraone、SX 3030、(3R)-2\'-[(4-bromo-2-fluorophenyl)methyl]spiro[pyrrolidine-3,4\'-pyrrolo[1,2-a]pyrazine]-1\',2,3\',5-tetrone
CAS号
147254-64-6
分子式
C17H11BrFN3O4
分子量
420.189
精确质量
418.992
PSA
91.97
LOGP
1.5279
编号系统
UNII
Z26P56GFTV
物化性质
密度
1.83g/cm3
沸点
702.7ºC at 760mmHg
闪点
378.8ºC
折射率
1.749
蒸汽压
1.36E-19mmHg at 25°C
安全信息
危险性描述
H315; H319; H335
信号词
Warning
危险性防范说明
P280; P304 + P340 + P312; P305 + P351 + P338; P337 + P313
危险标志
GHS07
合成路线